贫血患者择期腹主动脉瘤腔内修复术围术期输血与结局
基于VQI数据库2008-2017年择期EVAR患者,纳入9232例贫血患者,其中1866例接受围术期输血。输血与住院死亡和并发症风险显著升高相关,校正后住院死亡OR为4.38(95%CI 2.72-7.05),任何住院并发症OR为4.31(95%CI 3.47-5.34)。
要点
- 贫血患者择期EVAR围术期输血与住院死亡风险升高近4.4倍独立相关。
- 输血还与心肌梗死、心衰、心律失常、肾脏并发症、腿缺血、呼吸并发症和再手术率升高相关。
- 轻度贫血患者输血后住院死亡OR达5.7(95%CI 1.78-18.0),风险更突出。
核心结论
- 贫血患者择期EVAR围术期输血与死亡和住院并发症风险升高相关,即使校正合并症和手术因素后仍显著。
- 数据提示血管外科EVAR患者限制性输血可能更安全,贫血的药物治疗可能有必要,但需进一步研究评估有效性。
研究设计与样本
- 回顾性队列研究,查询Vascular Quality Initiative数据库2008至2017年择期EVAR患者。
- 共27777例EVAR患者,其中9232例贫血患者纳入研究,贫血定义为男性血红蛋白10-13 g/dL或女性10-12 g/dL为轻度,<10 g/dL为中重度。
- 主要结局为住院死亡和并发症。
主要发现
- 贫血患者中1866例(五分之一)接受围术期输血,输血患者更可能有心血管疾病史。
- 轻度贫血输血 vs 未输血住院死亡率3.6% vs 0.4%(P < .001),中重度贫血4.5% vs 1.3%(P < .01)。
- 输血患者心肌梗死、充血性心力衰竭、心律失常、肾脏并发症、腿缺血、呼吸并发症和再手术率均更高,30天死亡率也更高(P < .001)。
- 校正人口学、合并症和手术因素后,输血与住院死亡OR 4.38(95%CI 2.72-7.05,P < .001)和任何住院并发症OR 4.31(95%CI 3.47-5.34,P < .001)相关。
- 轻度贫血患者中,输血与住院死亡OR 5.7(95%CI 1.78-18.0)和并发症OR 4.3(95%CI 3.46-5.29)相关。
临床怎么用
- 对择期EVAR贫血患者应审慎评估围术期输血指征,优先考虑限制性输血策略。
- 可考虑对贫血进行内科管理以降低死亡和并发症风险,但有效性尚待进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although blood transfusion can be lifesaving in active hemorrhage or severe anemia, it is also associated with increased morbidity and mortality. Several trials have established this risk and therefore defined a restrictive standard for transfusion, but this threshold and the risk of transfusions have not been specifically examined in vascular surgery patients. We therefore sought to assess transfusion practices and outcomes of anemic patients undergoing elective endovascular aneurysm repair (EVAR). METHODS: The Vascular Quality Initiative database was queried for patients undergoing EVAR between the years 2008 and 2017. Anemic patients were included in the study and were further stratified into mild anemia, defined by a hemoglobin level of 10 to 13 g/dL in men or 10 to 12 g/dL in women, and moderate to severe anemia, defined by a hemoglobin level <10 g/dL. The primary study outcomes were in-hospital mortality and complications. RESULTS: Among 27,777 EVAR patients, one-third (n = 9232) were anemic and included in the study. One-fifth (n = 1866) of anemic patients received a perioperative transfusion. Transfused patients were more likely to have a history of cardiovascular disease. In-hospital mortality was significantly higher for anemic patients who received transfusions, both in mild anemia (mortality, 3.6% vs 0.4% in no transfusion; P < .001) and in moderate to severe anemia (4.5% vs 1.3%; P < .01). Morbidity was also significantly higher, with anemic patients who received a transfusion having higher rates of myocardial infarction, congestive heart failure, dysrhythmias, renal complications, leg ischemia, respiratory complications, and reoperation compared with anemic patients who did not receive any transfusion. The 30-day mortality was also higher in transfused patients (P < .001). After adjustment for patients' demographics, comorbidities, and operative factors, transfusion in anemic patients was associated with a nearly 4.4-fold increased odds of in-hospital mortality (odds ratio [OR], 4.38; 95% confidence interval [CI], 2.72-7.05; P < .001) and 4.3-fold higher odds of any in-hospital complication (OR, 4.31; 95% CI, 3.47-5.34; P < .001). This was more pronounced among patients with mild anemia, with 5.7 times (OR, 5.7; 95% CI, 1.78-18.0) and 4.3 times (OR, 4.3; 95% CI, 3.46-5.29) the odds of in-hospital mortality and complications, respectively. CONCLUSIONS: Among anemic patients undergoing elective EVAR, transfusion is associated with an increased risk of death and in-hospital complications, even after controlling for patients' comorbidities and operative factors. These data suggest that the restrictive use of blood transfusions might be safer in vascular surgery EVAR patients. Medical management of anemia may be warranted in these patients to reduce morbidity and mortality; however, further studies are needed to evaluate effectiveness.
引用
- Dakour-Aridi H, Giuliano K, Locham S, et al. Perioperative blood transfusion in anemic patients undergoing elective endovascular abdominal aneurysm repair. J Vasc Surg. 2019. PMID: 31176635. doi:10.1016/j.jvs.2019.02.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。